Shereen Hamed

Shereen Hamed

Auto-generated profile, based on publicly available information

Shereen Hamed

Department of Medical Histology and Cell Biology, Faculty of Medicine, Mansoura University, Mansoura 35516, Egypt

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 August 2022 in Cells
Verified
Journal Article
Open access
PDF file
MAMohamed Adel
Mohamed Adel
HEHassan Reda Hassan Elsayed
Hassan Reda Hassan Elsayed
MEMohammed Helmi ElNabalway
Mohammed Helmi ElNabalway
SHShereen Hamed
Shereen Hamed
AEAmira Eladl
Amira Eladl
MRMohammed Rami Rabei
Mohammed Rami Rabei
Long-term use of Glucocorticoids produces skeletal muscle atrophy and microvascular rarefaction. Hydrogen sulfide (H2S) has a potential role in skeletal muscle regeneration. However, the mechanisms still need to be elucidated. This is the first study to explore the effect of Sodium hydrosulfide (NaHS) H2S donor, against Dexamethasone (Dex)-induced soleus muscle atrophy and microvascular rarefaction and on muscle endothelial progenitors and M2 macrophages. Rats received either; saline, Dex (0.6 mg/Kg/day), Dex + NaHS (5 mg/Kg/day), or Dex + Aminooxyacetic acid (AOAA), a blocker of H2S (10 mg/Kg/day) for two weeks. The soleus muscle was examined for contractile properties. mRNA expression for Myostatin, Mechano-growth factor (MGF) and NADPH oxidase (NOX4), HE staining, and immunohistochemical staining for caspase-3, CD34 (Endothelial progenitor marker), vascular endothelial growth factor (VEGF), CD31 (endothelial marker), and CD163 (M2 macrophage marker) was performed. NaHS could improve the contractile properties and decrease oxidative stress, muscle atrophy, and the expression of NOX4, caspase-3, Myostatin, VEGF, and CD31 and could increase the capillary density and expression of MGF with a significant increase in expression of CD34 and CD163 as compared to Dex group. However, AOAA worsened the studied parameters. Therefore, H2S can be a promising target to attenuate muscle atrophy and microvascular rarefaction.

13 October 2021 in Heliyon
Verified
Journal Article
Open access
MEMona G. Elhadidy
Mona G. Elhadidy
AEAhlam Elmasry
Ahlam Elmasry
HEHassan Reda Hassan Elsayed
Hassan Reda Hassan Elsayed
MEMohammad El-Nablaway
Mohammad El-Nablaway
SHShereen Hamed
Shereen Hamed
MRMohammed Rami Rabei
Mohammed Rami Rabei
This study aimed to explore the potential protective effect of α-lipoic acid on busulfan-induced pulmonary fibrosis in rats. Eighteen adult male rats were divided into 3 groups; control, busulfan, and busulfan plus α-lipoic acid groups. Lung index ratio, serum level of proinflammatory cytokine were assessed. The activities of antioxidant enzymes and lipid peroxidation products were estimated in the lung tissues in addition to the histopathological analyses. The deposition of the collagen in the lung tissues was evaluated by Sirius red staining. The expressions of α-smooth muscle actin (α-SMA), TNF-α, and Caspase 3 were determined immunohistochemically. The pulmonary expression of COX-2 and NOX-4 mRNA was assessed using qRT-PCR. Administration of ALA significantly protect the lung against BUS-induced pulmonary fibrosis, besides the upregulation of antioxidants, and downregulation of pro-inflammatory cytokines. Also, it reduced collagen deposition that associated with a decreased expression of α-SMA, TNF-α, and Caspase 3 in the lung tissues. Moreover, ALA significantly upregulated the expression of COX-2 concomitant with the downregulation of elevated NOX-4. ALA attenuates the lung cytotoxicity of busulfan through its anti-inflammatory, anti-apoptotic, and antifibrotic effects that may be mediated by upregulation of COX-2 and downregulation of NOX-4.

21 February 2022 in Cells
Verified
Journal Article
Open access
PDF file
HEHassan Reda Hassan Elsayed
Hassan Reda Hassan Elsayed
RERanda El-Gamal
Randa El-Gamal
MRMohammed Rami Rabei
Mohammed Rami Rabei
MEMona gaber Elhadidy
Mona gaber Elhadidy
SHShereen Hamed
Shereen Hamed
MEMohammed Helmi ElNabalway
Mohammed Helmi ElNabalway
Obesity causes renal changes (ORC), characterized by defective renal autophagy, lipogenesis, enhanced macrophage infiltration and apoptosis. We hypothesize that Dasatinib, a tyrosine kinase inhibitor, may ameliorate changes associated with obesity. We the mice with either Obesogenic diet (OD) or a standard basal diet. After 12 weeks, the mice received either vehicle or Dasatinib 4 mg/kg/d for an additional four weeks. We examined serum creatinine, urea, lipid profile and renal cortical mRNA expression for lipogenesis marker SREBP1, inflammatory macrophage marker iNOS and fibrosis markers; TGFβ and PDGFA genes; immunohistochemical (IHC) staining for CD68; inflammatory macrophage marker and ASMA; fibrosis marker, LC3 and SQSTM1/P62; autophagy markers and western blotting (WB) for caspase-3; and, as an apoptosis marker, LC3II/I and SQSTM1/P62 in addition to staining for H&E, PAS, Sirius red and histopathological scoring. Dasatinib attenuated renal cortical mRNA expression for SREBP1, iNOS, PDGFA and TGFβ and IHC staining for CD68, ASMA and SQSTM1/P62 and WB for caspase-3 and SQSTM1/P62, while elevating LC3 expression. Moreover, Dasatinib ameliorated ORC; glomerulosclerosis, glomerular expansion, tubular dilatation, vacuolation and casts; inflammatory cellular infiltration; and fibrosis. Dasatinib is a promising therapy for ORC by correcting autophagy impairment, attenuating lipogenesis, apoptosis and macrophage infiltration by inducing antifibrotic activity.

31 October 2021 in Mansoura Medical Journal
Verified
Journal Article
Open access
PDF file
SASara Al-Sherief
Sara Al-Sherief
AHAzza El- Hadidy
Azza El- Hadidy
SHShereen Hamed
Shereen Hamed
AEAmany El-Hawwary
Amany El-Hawwary
SMShireen Mazroa
Shireen Mazroa
Background: Arthritis is the most common joint disorder. The most significant structural change seen in arthritis is the degeneration of the articular cartilage. Numerous animal models are used to reproduce arthritis. In this paper, we assessed the ability of complete Freund's adjuvant (CFA) to induce degenerative changes of hyaline articular cartilage in rat chronic arthritis model. Methods: In this study, 42 adult male albino rats were used, divided into: control group I (18 rats) and arthritis group II (24 rats). Arthritis was induced unilaterally by a single intra-articular injection of 125 μl of CFA in the right knee joint of each rat. The samples were collected 2, 6, and 10 weeks post-injection. Hematoxylin & Eosin (H&E) stain, Masson’s trichrome stain, Safranin O (S.O) stain were used to assess articular cartilage degeneration during inflammation. Results: The articular cartilage of rats of arthritis group II showed progressive inflammatory cell infiltration in the synovial membrane. Chondrocytes showed degeneration, hypertrophy and extensive proliferation. Moreover, the matrix exhibited fibrillations, fissuring, delamination and denudation with fibrous tissue within the denuded surface. The thickness of the articular cartilage, the collagen content and the proteoglycan content showed significant decrease in rats sacrificed after 10 weeks compared to rats sacrificed after 2 weeks and 6 weeks from the onset of the experiment. Conclusions: Intra-articular injection of complete Freund’s adjuvant induces progressive degeneration of the hyaline articular cartilage of the knee joint of rats. It can be useful for studies on mechanisms and strategy of treatment of knee joint arthritis.

16 July 2026 in Tissue and Cell
Verified
Journal Article
Closed access
Rabab S. HamadRabab S. Hamad
Rabab S. Hamad
Sameh SaberSameh Saber
Sameh Saber
Elsayed Abdelhadi Hassan ElmorsyElsayed Abdelhadi Hassan Elmorsy
Elsayed Abdelhadi Hassan Elmorsy
MAMaha M. Amer
Maha M. Amer
MAMohamed Ali
Mohamed Ali
MAMohamed R. Abdel-Hamed
Mohamed R. Abdel-Hamed